Canopy Growth (CGC) stock Forecast for 2022 – 2026
Last update: October 6, 2022 (11:30)Sector: Healthcare
The share price of Canopy Growth Corp. (CGC) now
What analysts predict: $6.11
52-week high/low: $15.96 / $2.13
50/200 Day Moving Average: $3.228 / $5.55
This figure corresponds to the average price over the previous 50/200 days. For Canopy Growth stocks, the 50-day moving average is the resistance level today.
For Canopy Growth stocks, the 200-day moving average is the resistance level today.
Are you interested in Canopy Growth Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Canopy Growth stock price in 2022, 2023, 2024, 2025, 2026. How much will one Canopy Growth share be worth in 2022 - 2026?
When should I take profit in Canopy Growth stock? When should I record a loss on Canopy Growth stock? What are analysts' forecasts for Canopy Growth stock? What is the future of Canopy Growth stock?
We forecast Canopy Growth stock performance using neural networks based on historical data on Canopy Growth stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Canopy Growth stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Canopy Growth shares. This happens once a day.
Historical and forecast chart of Canopy Growth stock
The chart below shows the historical price of Canopy Growth stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Canopy Growth stock price can be found in the table below.
Long-term forecasts by years.
Canopy Growth daily forecast for a month
Canopy Growth Daily Price Targets
Canopy Growth Stock Forecast 10-08-2022.
Pessimistic target level: 2.98
Optimistic target level: 3.11
Canopy Growth Stock Forecast 10-09-2022.
Pessimistic target level: 3.00
Optimistic target level: 3.11
Canopy Growth Stock Forecast 10-10-2022.
Pessimistic target level: 2.97
Optimistic target level: 3.04
Canopy Growth Stock Forecast 10-11-2022.
Pessimistic target level: 2.91
Optimistic target level: 3.04
Canopy Growth Stock Forecast 10-12-2022.
Pessimistic target level: 3.01
Optimistic target level: 3.12
Canopy Growth Stock Forecast 10-13-2022.
Pessimistic target level: 3.08
Optimistic target level: 3.20
CGC (CGC) Monthly Stock Prediction for 2022
Canopy Growth forecast for this year
Canopy Growth Stock Prediction for Nov 2022
An downtrend is forecast for this month with an optimal target price of $2.58258. Pessimistic: $2.37. Optimistic: $2.75
Canopy Growth Stock Prediction for Dec 2022
An uptrend is forecast for this month with an optimal target price of $2.65618. Pessimistic: $2.41. Optimistic: $2.74
Canopy Growth (CGC) Monthly Stock Prediction for 2023
Canopy Growth (CGC) Monthly Stock Prediction for 2024
Canopy Growth (CGC) Monthly Stock Prediction for 2025
Canopy Growth (CGC) Monthly Stock Prediction for 2026
Canopy Growth information and performance
The Canopy Growth Corporation, together with its subsidiaries, manufactures, distributes and markets cannabis for recreational and medical purposes, primarily in Canada, the United States, Germany and the United Kingdom. It operates in two segments: cannabis, hemp and other consumer products; and hinged rivers. The company’s products include dried cannabis flowers, oils and concentrates, and soft capsules. It offers its products under Tweed, Quatreau, Deep Space, Healing Spectrum, First and Free, Taiwan Dollar, It Works, BioSteel, CraftGrow DNA Genetics, Tokyo Smoke, Changed, Delicious Parcels, Van der Pop, and Beans and Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and the NHL Alumni Association to study the efficacy of CBD-based therapy in alleviating persistent post-exposure symptoms. As of February 14, 2020, she operated 28 cannabis retail stores called Tweed or Tokyo Smoke. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smits Falls, Canada.
Canopy Growth Address
1 HERSHEY DRIVE, SMITH FALLS, ON, CA
Market Capitalization: 1 311 375 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: -533 744 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: None
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -0.192
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 3.485
Enterprise Value (EV) /Revenue
EV To EBITDA: -0.665
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 479979000
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.